42 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
Rank Status Study
1 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
2 Recruiting Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
3 Unknown  Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
4 Unknown  24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
Condition: Androgenetic Alopecia
Interventions: Device: iRestore Hair Rejuvenation System;   Device: sham device
5 Recruiting A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Condition: Androgenetic Alopecia
Interventions: Drug: SM04554;   Drug: Vehicle
6 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
7 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
8 Unknown  Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
Conditions: Impetigo;   Folliculitis;   Secondarily Infected Eczema;   Minor Soft Tissue Infections
Intervention: Drug: Retapamulin (Altabax)
9 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment
10 Unknown  Photodynamic Therapy for Permanent Hair Removal
Conditions: Hypertrichosis;   Hirsutism
Intervention: Procedure: application of a dye suspension followed by a laser intervention
11 Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: CB-03-01 solution;   Drug: Minoxidil Solution 5%;   Drug: Placebo solution
12 Recruiting Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Topical latanoprost 0.005%;   Drug: Topical betamethasone 0.05%
13 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome;   Unexplained Copper Deficiency
Intervention: Drug: Copper Histidine
14 Unknown  Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Condition: Female Pattern Hair Loss
Interventions: Drug: Spironolactone;   Drug: Minoxidil
15 Unknown  The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
16 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Triamcinolone 2.5 mg/ml;   Drug: Triamcinolone 5 mg/ml;   Drug: Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
17 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Conditions: Post Radiation/Chemotherapy Alopecia Presents With Hair Thinning.;   Post-burn Alopecia Presents With Hair Thinning.;   Cicatricial Alopecia Presents With Hair Thinning.;   Androgenetic Alopecia Presents With Hair Thinning;   Alopecia Due to Traumatic Injuries Presents With Hair Thinning.;   Alopecia Due to Skin Disease Presents With Hair Thinning.
Intervention: Device: Anchoring system
18 Unknown  Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
Conditions: Alopecia Areata;   Alopecia;   Balding
Interventions: Procedure: Hair transplantation;   Procedure: Hypodermic needle irritation
19 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
20 Unknown  Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years